Canada thistle is a serious weed of many crop, rangeland, pasture, and natural areas throughout North America. Aminopyralid is a new pyridine carboxylic acid herbicide that has activity on Canada thistle at lower use rates than current standard treatments. The objectives of this study were to compare aminopyralid efficacy, rates, and application timing with several commercial standards for Canada thistle control. Studies were conducted across the Great Plains at ten locations, which encompassed a wide range of environments. Aminopyralid provided Canada thistle control comparable to picloram, picloram + 2,4-D amine, and clopyralid and better control than clopyralid + 2,4-D amine, dicamba, dicamba + 2,4-D amine and dicamba + diflufenzopyr. Canada thistle control was similar when aminopyralid was applied between 0.08 and 0.11 kg ai/ha and application timing (spring bolting vs. fall rosette/regrowth) did not strongly influence control 1 yr after treatment (YAT). Aminopyralid provided effective Canada thistle control at lower use rates than current commercial standards and might be useful in areas where herbicides such as picloram and clopyralid are not recommended for use.
Chemical restrictions, ecological concerns, liability issues, and public sentiment present challenges to land managers attempting to control highly invasive plants like Canada thistle (Cirsium arvense [L.] Scop.). Although herbicide application can be an effective control strategy, increasing limitations force managers of sensitive environments (e.g., national parks, wildlife refuges, protected water-bodies or waterways) to search for effective control alternatives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.